Publications scientifiques

2548 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2020

JOURNALWorld journal of gastrointestinal oncology

PREMIER AUTEURTharin Z

TITREInfluence of primary tumor location and resection on survival in metastatic colorectal cancer.

ANNÉE2020

JOURNALEuropean journal of obstetrics, gynecology, and reproductive biology

PREMIER AUTEURZilliox M

TITREManagement of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.

ANNÉE2020

JOURNALLung cancer (Amsterdam, Netherlands)

PREMIER AUTEURBlons H

TITREPTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.

ANNÉE2020

JOURNALOncogene

PREMIER AUTEURBeck M

TITREThe atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanisms.

ANNÉE2020

JOURNALBlood

PREMIER AUTEURLe Gouill S

TITREIbrutinib, Obinutuzumab And Venetoclax In Relapsed and Untreated Patients with Mantle-Cell Lymphoma, a phase I/II trial.

ANNÉE2020

JOURNALPLoS computational biology

PREMIER AUTEURCakmakci D

TITREMachine learning assisted intraoperative assessment of brain tumor margins using HRMAS NMR spectroscopy.

ANNÉE2020

JOURNALBMJ supportive & palliative care

PREMIER AUTEURNeuzillet C

TITRENutrition and physical activity: French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC, SFP-APA, SFNCM, AFSOS).

ANNÉE2020

JOURNALBlood

PREMIER AUTEURMichallet AS

TITREA fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial.

ANNÉE2020

JOURNALEuropean journal of cancer (Oxford, England : 1990)

PREMIER AUTEURCottu P

TITREEvolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2-targeted treatments: Results from the french personalized reimbursement model database (2011-2018).

ANNÉE2020

JOURNALCell death & disease

PREMIER AUTEURRodriguez-Vargas JM

TITREParp3 promotes astrocytic differentiation through a tight regulation of Nox4-induced ROS and mTorc2 activation.

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques